Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan

This open-label, uncontrolled, single-arm, multicenter, phase 3 study evaluated the efficacy and safety of incobotulinumtoxinA in Japanese patients with blepharospasm. Eligible patients received incobotulinumtoxinA injections at fixed doses (50, 75, or 100 units [U] for those who had previously rece...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Toshiaki Goseki, Yoshihito Mochizuki, Akiko Masuda, Motohiro Kiyosawa, Ryosuke Miyamoto, Masato Wakakura, Akiko Yamagami, Yohei Mukai, Akihiro Shinkai, Mutsumi Iijima, Kousuke Baba, Hideki Chuman, Masahiro Hashizuka, Shohei Tateishi, Akiko Kimura
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2026-02-01
סדרה:	Toxins
נושאים:	blepharospasm botulinum toxin dystonia East Asia efficacy incobotulinumtoxinA
גישה מקוונת:	https://www.mdpi.com/2072-6651/18/2/109
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!